Daniele Laszlo

Daniele Laszlo

UNVERIFIED PROFILE

Are you Daniele Laszlo?   Register this Author

Register author
Daniele Laszlo

Daniele Laszlo

Publications by authors named "Daniele Laszlo"

Are you Daniele Laszlo?   Register this Author

32Publications

736Reads

29Profile Views

A MALT lymphoma prognostic index.

Blood 2017 09 18;130(12):1409-1417. Epub 2017 Jul 18.

Lymphoma Unit, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2017-03-771915DOI Listing
September 2017

Extracorporeal Photopheresis for Treatment of Acute and Chronic Graft Versus Host Disease: An Italian Multicentric Retrospective Analysis on 94 Patients on Behalf of the Gruppo Italiano Trapianto di Midollo Osseo.

Transplantation 2016 Dec;100(12):e147-e155

1 Hematology, Bone Marrow Transplantation Unit, Department of Clinical and Experimental Sciences, University of Brescia, Italy. 2 Immunohematology and Transfusion Medicine Unit, AO Spedali Cvili, Brescia, Italy. 3 SODc Terapia Cellulare e Medicina Trasfusionale, AOU Careggi, Firenze, Italy. 4 Divisione di Ematologia, Fondazione Policlinico Universitario Agostino Gemelli, Università Cattolica del Sacro Cuore, Roma, Italy. 5 SC Ematologia, Istituto Nazionale Tumori, Milano, Italy. 6 Clinica Ematologica e Unità di terapie Cellulari, DISM, Università di Udine, Italy. 7 Centro di Ricerca Emato-oncologica AIL (CREA) Brescia, AO Spedali Civili di Brescia, Italy. 8 Unità di Cellule Staminali, Istituto Europeo di Oncologia, Milano, Italy. 9 Medicina Trasfusionale, Azienda Ospedaliero-Universitaria di Udine, Italy. 10 UO di Emotrasfusione, Fondazione Policlinico Universitario Agostino Gemelli, Università Cattolica del Sacro Cuore, Roma, Italy. 11 Bone Marrow Transplant Unit SODc Ematologia, AOU Careggi, Firenze, Italy.

View Article

Download full-text PDF

Source
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/TP.0000000000001466DOI Listing
December 2016

Rituximab Maintenance for a Maximum of 5 Years After Single-Agent Rituximab Induction in Follicular Lymphoma: Results of the Randomized Controlled Phase III Trial SAKK 35/03.

J Clin Oncol 2016 Feb 28;34(5):495-500. Epub 2015 Dec 28.

Christian Taverna, Kantonsspital Münsterlingen, Münsterlingen; Felicitas Hitz, Kantonsspital St Gallen, St Gallen; Walter Mingrone, Kantonsspital Aarau/Olten, Olten; Thomas Pabst, Inselspital Bern; Christine Biaggi Rudolf, Stéphanie Rondeau, and Corinne Rusterholz, Swiss Group for Clinical Cancer Research SAKK, Bern; Daniel Rauch, Spital Thun Simmental, Thun; Andreas Lohri, Kantonsspital Liestal, Liestal; Ingmar A.F.M. Heijnen, University Hospital Basel, Basel; Emanuele Zucca and Michele Ghielmini, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland; Giovanni Martinelli, Anna Vanazzi, and Daniele Laszlo, Istituto Europeo di Oncologia, Milan, Italy; Lidija Cevreska, University Clinic for Hematology, Skopje, Macedonia; Auro del Giglio, ABC Fondation School of Medicine, Sao Paulo, Brazil; Johann Raats, Panorama Oncology Unit, Cape Town; and Daniel A. Vorobiof, Sandton Oncology Center, Johannesburg, South Africa.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.61.3968DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4872010PMC
February 2016

Core needle biopsy as a front line diagnostic approach for lymphoma patients.

Hematol Oncol 2015 Dec 2;33(4):247-9. Epub 2014 Jul 2.

European Institute of Oncology, Hemato-Oncology, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hon.2150DOI Listing
December 2015

Chlorambucil-rituximab as first-line therapy in patients affected by follicular non-Hodgkin's lymphoma: a retrospective single-centre study.

Hematol Oncol 2015 Dec 22;33(4):129-35. Epub 2014 Jul 22.

Division of Clinical Hemato-oncology, European Institute of Oncology, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hon.2154DOI Listing
December 2015

Plerixafor: what we still have to learn.

Expert Opin Biol Ther 2015 Feb 15;15(2):143-7. Epub 2014 Oct 15.

Hematology Institute, Hospital of Cremona , Cremona , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14712598.2015.971750DOI Listing
February 2015

Long-active granulocyte colony-stimulating factor for peripheral blood hematopoietic progenitor cell mobilization.

Expert Opin Biol Ther 2014 Jun 5;14(6):757-72. Epub 2014 Mar 5.

Department of Oncology and Hematology, Hematology and Bone Marrow Transplant Unit, Azienda Ospedaliera BMM , Via Cantaffio, 89133 Reggio Calabria , Italy

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14712598.2014.895809DOI Listing
June 2014

Factors affecting successful mobilization with plerixafor: an Italian prospective survey in 215 patients with multiple myeloma and lymphoma.

Transfusion 2014 Feb 19;54(2):331-9. Epub 2013 Jun 19.

Section of Hematology and BMT Unit, Cremona Hospital, Cremona, Italy; Department of Hematology and Oncological Sciences, Institute of Hematology "L. & A. Seràgnoli", University of Bologna, Bologna, Italy; Section of Hematology, University Hospital of Ancona, "Ospedali Riuniti", Ancona, Italy; Hemato-Oncology Unit, Istituto Europeo Oncologico, Milan, Italy; Section of Hematology, Reggio Calabria Hospital, Reggio Calabria, Italy; Section of Hematology, University Hospital of Bari, Bari, Italy; Section of Hematology, Tricase Hospital, Tricase, Italy; Section the of Hematology, Rimini Hospital, Rimini, Italy; Section of Hematology, University Hospital Ferrarotto, Policlinico Vittorio Emanuele, Catania, Italy; Section of Hematology, Humanitas Hospital; BMT Unit, S. Raffaele Hospital, Milan, Italy; Section of Hematology, Hospital Casa Sollievo Sofferenza, S. Giovanni Rotondo, Italy; Section of Hematology, Bergamo Hospital, Bergamo, Italy; Section of Hematology and BMT Unit, University Hospital "Careggi", Florence, Italy.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/trf.12265
Publisher Site
http://dx.doi.org/10.1111/trf.12265DOI Listing
February 2014

Efficacy of photopheresis extracorporeal procedure as single treatment for severe chronic GVHD: a case report.

Transfus Apher Sci 2013 Oct 13;49(2):205-7. Epub 2013 Mar 13.

European Institute of Oncology, Hematoncology Divisione, Milan, Italy; Humanitas Cancer Center, Istituto Clinico Humanitas, Istituto Di Ricovero e Cura a Carattere Scientifico, Rozzano, Milan, Italy. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S14730502130002
Publisher Site
http://dx.doi.org/10.1016/j.transci.2013.01.013DOI Listing
October 2013

Who should be really considered as a poor mobilizer in the plerixafor era?

Transfus Apher Sci 2012 Aug 4;47(1):27-32. Epub 2012 Apr 4.

Stem Cell Collection Unit, European Institute of Oncology, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.transci.2012.03.004DOI Listing
August 2012

Fludarabine combination regimen severely affected peripheral blood stem cell mobilization.

Acta Haematol 2004 ;111(4):228-9

Department of Hematoncology, European Institute of Oncology, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000077572DOI Listing
June 2004

Local thrombolytic therapy in cancer patients with central venous catheter occlusion in urgent need of antiblastic treatment: a single institution experience.

J Thromb Thrombolysis 2003 Apr;15(2):109-11

Hematoncology Division, European Institute of Oncology, Milan, Italy.

View Article

Download full-text PDF

Source
April 2003